BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers

Gui-Hua Wang1, Chun-Mei Zhao1, Ying Huang1

  • 1Department of Laboratory Medicine, Department of Tissue Bank, Affiliated Hospital of Nantong University, School of Public Health, Nantong University, Nantong, Jiangsu, PR China, 226001.

Human Pathology
|November 12, 2017
PubMed

Insights

BRCA1 and BRCA2 protein expression in digestive cancers impacts patient survival. High cytoplasmic expression of these genes indicates a favorable prognosis, while high nuclear BRCA1 expression suggests a poor outcome.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • BRCA1 and BRCA2 genes are crucial for maintaining genome integrity.
  • Their deregulation is linked to tumor development and chemotherapy resistance.

Purpose of the Study:

  • To investigate BRCA1 and BRCA2 protein expression in four digestive system cancers.
  • To correlate expression patterns with clinical parameters and patient survival.

Main Methods:

  • Immunohistochemistry on tissue microarrays.
  • Analysis of 1546 samples from gastric, colorectal, hepatocellular, and pancreatic cancers.
  • Correlation analysis with clinical data and overall survival.

Main Results:

  • Low cytoplasmic BRCA1/BRCA2 expression correlated with advanced tumor-lymph node-metastasis stage.
  • High nuclear BRCA1 expression correlated with advanced tumor stages.
  • High cytoplasmic BRCA1/BRCA2 expression predicted favorable overall survival; nuclear BRCA1 predicted poor outcomes.

Conclusions:

  • BRCA1 and BRCA2 protein expression levels are associated with patient prognosis in digestive cancers.
  • Cytoplasmic and nuclear expression patterns offer distinct prognostic information.
  • BRCA1 and BRCA2 can serve as potential clinicopathological biomarkers for digestive system cancer prognosis.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K